TGTX Latest Headlines

TG Therapeutics Extends Azer-Cel Safety Tracking With 15-Year Follow-Up Study

at www.tipranks.com (Thu, 29-Oct 12:31 PM)

TG Therapeutics spotlights Phase 1 azer-cel data in progressive MS, with 89% stable or improved disability at Day 90

Market Chameleon (Mon, 26-Oct 8:56 AM)

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), IQVIA Holdings (IQV) and TG Therapeutics (TGTX)

at www.tipranks.com (Mon, 26-Oct 8:41 PM)

TG Therapeutics Lifts 2026 Revenue Targets as BRIUMVI Momentum Accelerates—Key Data and Outlook

Market Chameleon (Mon, 3-Aug 7:33 AM)